Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells

Author:          

Publisher: Spandidos Publications

E-ISSN: 1791-2423|47|1|315-324

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.47, Iss.1, 2015-01, pp. : 315-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content